Diakonessenhuis Utrecht
Hospital
Location:
Utrecht,
Netherlands (NL)
ISNI: 0000000406319258
ROR: https://ror.org/01nrpzj54
Show on Map:
Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective (2025)
Hannoun-Levi JM, Margenthaler J, Anderson B, Di Micco R, Arthur D, Aznar M, Berry MP, et al.
Journal article
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease (2025)
Bakker WM, Heerspink HJ, Berger SP, Wanner C, Badve SV, Arnott C, Abrahams AC, et al.
Journal article
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial (2025)
Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B, De Rose F, et al.
Journal article
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures (2021)
Meattini I, Poortmans PM, Marrazzo L, Desideri I, Brain E, Hamaker M, Lambertini M, et al.
Journal article